DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising advancements across numerous clinical and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA presents a safer, far more dependable choice for therapeutic u